MRO
40
-15
LEN
52
2
ROST
52
5
DG
4
2
MAS
56
5
HOG
33
4
MAR
65
2
EFX
36
4
D
45
5
HAL
60
2
WEC
55
2
HPQ
57
-2
MTCH
42
5
ROP
59
5
OI
42
5
APH
67
3
STX
56
4
MLM
51
3
CRM
65
6
MDLZ
36
2
MRO
40
-15
LEN
52
2
ROST
52
5
DG
4
2
MAS
56
5
HOG
33
4
MAR
65
2
EFX
36
4
D
45
5
HAL
60
2
WEC
55
2
HPQ
57
-2
MTCH
42
5
ROP
59
5
OI
42
5
APH
67
3
STX
56
4
MLM
51
3
CRM
65
6
MDLZ
36
2
Financhill
Back

Verve Therapeutics Vs. Sage Therapeutics Industry Stock Comparison

Sell
1

VERV
Verve Therapeutics

Last Price:
4.86
Seasonality Move:
-24.87%
Sell
22

SAGE
Sage Therapeutics

Last Price:
5.14
Seasonality Move:
10.16%
Sell
1
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics a Buy, Sell or Hold?

  • The current Verve Therapeutics [VERV] share price is $4.60. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy, Sell or Hold?

  • The current Sage Therapeutics [SAGE] share price is $4.85. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VERV Stock Price Chart

What is Verve Therapeutics's stock price today?

  • The Verve Therapeutics share price today is $4.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing slight buying pressure.

SAGE Stock Price Chart

What is Sage Therapeutics's stock price today?

  • The Sage Therapeutics share price today is $4.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.

VERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 34.97 Sell
Chaikin Money Flow: 386531 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.09 - 6.29) Sell
Bollinger Bands (100): (4.83 - 6.53) Sell

SAGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.61 Sell
Relative Strength Index (14 RSI): 28.5 Sell
Chaikin Money Flow: -1104590 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.24 - 7.58) Sell
Bollinger Bands (100): (6.19 - 10.13) Sell

VERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.11 Sell
20-day SMA: 5.71 Sell
50-day SMA: 5.37 Sell
200-day SMA: 7.35 Sell
8-day EMA: 5.02 Sell
20-day EMA: 5.4 Sell
50-day EMA: 5.5 Sell
200-day EMA: 7.43 Sell

SAGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.17 Sell
20-day SMA: 6.08 Sell
50-day SMA: 6.76 Sell
200-day SMA: 12.05 Sell
8-day EMA: 5.19 Sell
20-day EMA: 5.83 Sell
50-day EMA: 6.75 Sell
200-day EMA: 12.08 Sell

Verve Therapeutics Earnings Growth & VERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.

Sage Therapeutics Earnings Growth & SAGE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.

Verve Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):